Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Particle Accelerators × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Glioma 1 Glioblastoma 1

Interventions

Temozolomide 341 Radiotherapy 201 Bevacizumab 154 Magnetic Resonance Spectroscopy 143 Radiosurgery 126 Cyclophosphamide 80 Irinotecan 68 Carboplatin 68 pembrolizumab 64 Etoposide 64 Radiation 63 Nivolumab 52 Surgical Procedures, Operative 45 Specimen Handling 45 Filgrastim 44 Cisplatin 40 Blood Specimen Collection 38 Melphalan 36 Vincristine 32 Topotecan 32 Pemetrexed 32 Radiotherapy, Intensity-Modulated 31 Surveys and Questionnaires 30 Lomustine 30 Ipilimumab 29 Drug Therapy 29 Everolimus 28 Magnetic Resonance Imaging 27 fludarabine 26 Erlotinib Hydrochloride 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01700569 2023-02-21

FOLAGLI

Institut Cancerologie de l'Ouest

Phase 1 Terminated

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡